期刊文献+

肥厚型心肌病的治疗

Treatment of Hypertrophic Cardiomyopathy
下载PDF
导出
摘要 肥厚型心肌病(HCM)是显性遗传病,位于常染色体上,其主要特征是左心室壁增厚,常累及室间隔,猝死率较高,目前已经引起临床的重视。随着医学的发展及对该病认识的不断加深,越来越多的治疗方法应用于临床。本文现对该病的药物治疗、介入治疗、起搏器治疗及精准治疗方面进行阐述,旨在为临床治疗及研究提供参考。 Hypertrophic cardiomyopathy(HCM)is a dominant genetic disease that is located on the autosomal chromosome.It is mainly characterized by thickening of the left ventricle wall,often involving the ventricular septum,and a high rate of sudden death.It has attracted clinical attention.With the development of medicine and the deepening of understanding of the disease,more and more treatment methods are applied in the clinic.This article describes the drug treatment,interventional therapy,pacemaker therapy,and precision treatment of the disease,and aims to provide a reference for clinical treatment and research.
作者 迟令福 张峰 CHI Ling-fu;ZHANG Feng(Department of Internal Medicine,Subject Four,Tianjin Teda International Cardiovascular Hospital,Tianjin 300457,China)
出处 《医学信息》 2020年第3期63-65,共3页 Journal of Medical Information
关键词 肥厚型心肌病 室间隔切除术 室间隔酒精消融术 经皮室间隔射频消融术 精准治疗 Hypertrophic cardiomyopathy Ventricular septal resection Ventricular septal alcohol ablation Percutaneous ventricular septal radiofrequency ablation Precision treatment
  • 相关文献

参考文献8

二级参考文献125

  • 1辽宁省PTSMA治疗HOCM协作组.经皮经冠状动脉室间隔化学消融术治疗肥厚性梗阻型心肌病的近期疗效观察.中华心血管病杂志,2001,29:8-11.
  • 2Li ZQ, Cheng TO, Zhang WW, et al. Pereutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy; The Chinese experience in 119 patients from a single center. Int J Cardiol, 2004, 93: 197-202.
  • 3Knight CJ. Five years of percutaneous transluminal septal myocardial ablation. Heart, 2000, 83: 255-256.
  • 4Veselka J, Duchonovh R, P a lenickova J, et al. Impact of ethanol dosing on the long-term outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy: a single-center prospective, and randomized study. Circ J, 2006,70: 1550-1552.
  • 5Bonne G, Carrier L, Richard P, et al. Familial hypertrophic cardiomyopathy: from mutations to functional defects. Circ Res, 1998, 83: 580-593.
  • 6Teare D.Asymmetrical hypertrophy of the heart in young adults[J].Br Heart J,1958,20(1):1-8.
  • 7Maron BJ.Hypertrophic cardiomyopathy:a systematic review[J].JAMA,2002,287(10):1308-1320.
  • 8Maron BJ,Mc Kenna WJ,Danielson GK,et al.ACC/ESC clinicalexpert consensus document on hypertrophic cardiomyopathy[J].JACC,2003,42(9):1687-1713.
  • 9Seidman CE,Seidman JG.Identifying sarcomere gene mut-ations in hypertrophic cardiomyopathy:a personal hist ory[J].Circ Res,2011,108(6):743-750.
  • 10Maron MS,Maron BJ,Harrigan C,et al.Hypertrophic cardiomyopathyphenotype revisited after 50 years with cardio vascular magneticresonance[J].J Am Coll Cardiol,2009,54(3):220-228.

共引文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部